Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9279019
Human monoclonal antibodies specific for CD22
granted patentUS 9277748
Agonist/antagonist compositions and methods of use
granted patentUS 9272023
Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis
granted patentUS 9273121
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal
granted patentUS 9273124
Monoclonal antibodies that react with the capsule of Bacillus anthracis
granted patentUS 9273136
Fully human anti-human NKG2D monoclonal antibodies
granted patentUS 9265818
Genetically modified Babesia parasites expressing protective tick antigens and uses thereo
granted patentUS 9266928
Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved ant
granted patentUS 9266960
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa
granted patentUS 9260504
N- and C-terminal substituted antagonistic analogs of GH-RH
granted patentUS 9259452
Deacetylase inhibitor therapy
granted patentUS 9259463
Chlamydia vaccine
granted patentUS 9254319
Compositions and methods for generating an immune response
granted patentUS 9248145
Two alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and c
granted patentUS 9248179
Pan-lyssavirus vaccines against rabies
granted patentUS 9249217
Bispecific EGFRvIII x CD3 antibody engaging molecules
granted patentUS 9243036
Anti-microbial activity of synthetic peptides
granted patentUS 9241981
Use of a food additive based on at least one phytonutrient for stimulating vaccine immunit
granted patentUS 9238800
Avian adenoassociated virus and uses thereof
granted patentUS 9238069
Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in c
granted patentUS 9238684
SPANX-B polypeptides and their use
granted patentUS 9238799
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
granted patentUS 9233973
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor
granted patentUS 9228171
Regulatory B cells (tBREGS) and their use
granted